Kwarlay.com

Navigating the News Maze with Clarity

Medicine

FDA Approves Revuforj to Treat R/R Acute Leukemia with KMT2A Translocation

Syndax describes the drug as the first of its kind.

LEAVE A RESPONSE

Your email address will not be published. Required fields are marked *